Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher P. Molineaux Insider Profile
4 Followers
Christopher P. Molineaux, Director at Aclaris Therapeutics, holds 48.50K shares in Aclaris Therapeutics (Ticker: ACRS). Most recently, Christopher P. Molineaux Bought $16,500 shares of Aclaris Therapeutics on Jun 22, 2023 for an estimated value of 23.27K.
Christopher P. Molineaux Aclaris Therapeutics (ACRS)Director
Aclaris Therapeutics (ACRS)
Director
Ranked #93,603 out of 98,743 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-69.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher P. Molineaux's holdings
Insider Roles
Director
Roles that Christopher P. Molineaux holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 21, 2017 - Mar 21, 2018
Return:-37.20%
The most profitable trade made by Christopher P. Molineaux
Christopher P. Molineaux's Trading History
List of latest transactions for each holding click on a transaction to see Christopher P. Molineaux's performance on stock
You May Also Like
Christopher P. Molineaux insider profile FAQ
What is the percentage of profitable transactions made by Christopher P. Molineaux?
The percentage of profitable transactions made by Christopher P. Molineaux is 0%.
What is the average return per transaction made by Christopher P. Molineaux?
The average return per transaction made by Christopher P. Molineaux is -69.20%.
What stocks does Christopher P. Molineaux hold?
Christopher P. Molineaux holds: ACRS stocks.
What was Christopher P. Molineaux’s latest transaction?
Christopher P. Molineaux latest transaction was an Informative Buy of $23.27K.
What was Christopher P. Molineaux's most profitable transaction?
Christopher P. Molineaux’s most profitable transaction was an Informative Buy of ACRS stock on March 21, 2017. The return on the trade was -37.20%.
What is Christopher P. Molineaux's role in Aclaris Therapeutics?
Christopher P. Molineaux's role in Aclaris Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.